KNSA Competitors & Alternatives

Compare Kiniksa Pharmaceuticals Ltd with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

KNSA

Main Stock
$95.76
Tradestie Score
45
Market Cap
$2.86B
P/E Ratio
74.8
Revenue Growth
0.6%
Analyst Upside
+14.3%

Top Competitors

45 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
VTRS Viatris Inc. Common Stock
$21.06
$11.76B - 45 Compare
ELAN Elanco Animal Health Incorporated Common Stock
$26.48
$10.33B - 29 Compare
RGC Regencell Bioscience Holdings Limited Ordinary Shares
$5.41
$7.83B - 59 Compare
RYTM Rhythm Pharmaceuticals, Inc. Common Stock
$112.16
$6.64B - 29 Compare
KRYS Krystal Biotech, Inc. Common Stock
$308.81
$5.20B 41.6 52 Compare
ALKS Alkermes Inc. plc
$47.89
$5.06B - 33 Compare
MIRM Mirum Pharmaceuticals, Inc. Common Stock
$94.61
$3.67B - 40 Compare
LNTH Lantheus Holdings, Inc
$101.60
$3.51B 25.3 49 Compare
SRRK Scholar Rock Holding Corporation Common Stock
$46.60
$3.33B - 32 Compare
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock
$21.71
$3.26B 53.5 50 Compare

Data updated: Nov 12, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

45 stocks in this industry